Cboe UK Alternative 100 Net Total Return (BUKALTN) ニュース

The CEO of OTCMarkets provided an update to that March of 2021 article in September of 2023:
https://blog.otcmarkets.com/2023/09/14/the-expert-market-its-larger-role-post-rule-15c2-11/

Hoskuld, no harm no foul. I am pleased to say to you that I firmly believe that if 2-73 is approved by the EMA and the FDA you will be making a lot more with the sp being way north of $150. Happy new year to you and everyone.

Best call of 2024: Bail out of APRU in April, when prices peaked for the year.

I sold out of APRU

$HCWC 1.25 high of day

Nice development. Adding! $AABB to..da..Moon!

💥🤘 >> $AURI

I don't think he deceived us but the timing of the announcements on partners was strange. The day of or right before the 2023 and 2024 AGM's. I believe he asked for a favor from those two outfits because he was under the gun. To also reaffirm in a PR in June 2024 that we would be something by year's

I don't think volatility is done and prior price action following big jumps, let's see how the MM roles.

Two Jews trading sardines on the sardines exchange, one named Izzy, one named Abie
Izzy tries some and says to Abie, “these sardines taste terrible”
And Abie says to Izzy, “those aren’t the eating sardines, those are the trading sardines”

No, buy a stock and then announce your exit for profits!! No make believe!!

From today’s WSJ – great insight as to why it is so difficult and takes so long to get things done quickly in the fabs.
Paste this in your browser-

https://www.wsj.com/tech/ai/asml-euv-machine-lithography-chips-967954d0

This one Dutch company is responsible for a

VOLUME 

3,150,000

We've dramatically strengthened our financial health, improving our shareholder equity from approximately -$7.164M to -$1.176M
Chicken feed to what's coming. 😁

foxo.....cgbs..................................https://stockcharts.com/h-sc/ui?s=cgbs&p=D&yr=0&mn=3&dy=0&id=p11960084343

If Merck or any big pharma was seriously interested and they thought DCVAX was revolutionary, they wouldn’t waste time and risk having one of their competitors outdo them

Did you ever think that perhaps Merck is buying up the competition during low valuations, knowing that once it mak

Notice, the New Years message says nothing about IO. That’s not an accident or oversight.

Appreciate your comments, you consistently add depth through counterpoint to the conversation. However, you are comparing apples to oranges, again.

The PEM electrolyzer is currently the more efficient and appropriate variety for solar.

Using the otherwise unused excess

Left some on the table but was up over 200% green's green!

That was hilarious! Those photoshopped Yellen photos were awesome! I also watched the rest of the video and found his analysis interesting. Particularly the gold price and gold open interest chart at about 20 minutes into the video.

And much faster than the previous year!

Jon

BREA low share count borrowed out 23 %

Anyone listen to the "meeting"?

Agreed...🥳

Looking forward to January!

I believe the chances of a willing buyout pending an EMA (and a potential FDA) decision is quite low. After an approval (or two), I think the most probable end game is a very highly priced stock-for-stock buyout. Just my opinion.

Agree. BP will not pay up big until the approvals are